Objective
The SingHealth Duke-NUS Academic Medicine (AM) Research Grant 2.0 FY2025 is to provide funding support to deserving translational and clinical research within the SingHealth Duke-NUS Academic Medicine Centre (AMC).
Special Category Grant:
Health Services Research - HEalth Services Research and Analytical Technologies for SingHealth (HEARTS)
Note:
A certain amount of funding has been set-aside to allow grant applications under this category to be reviewed separately by the respective platform-specific panels.
To apply for the Special Category Grants, please ensure that you meet the relevant guidelines listed under the specific category prior to the application (refer to "SingHealth Duke-NUS AM Research Grant 2.0 FY2025 - Guidelines").
The type of research supported under Special Category is:
Funding Details
The grant award is up to S$65,000 over a period of 2 years.
Eligibility Criteria
Upon award of the grant applied for, applicants must not have received funding to conduct their own research project which cumulatively exceeds $300,000. This can be funding from any source e.g., internal, external, philanthropy or industry (i.e., If applicant has already been awarded $150K in research funding in the past, (s)he can only apply for less than $150K of subsequent internal funding as the ultimate intent is for SingHealth researchers to win national or external funding).
Residents in training programmes under SingHealth - who must obtain the appropriate endorsement from their Residency Programme Directors (*new*), HOD and ACP Vice Chairs, may also apply, subject to all other terms and conditions of the specific grant-type.
Applicants must not have held any national grants or international grants as a PI/Co-PI prior to the award.
Association/Affiliation with an Academic Clinical Programme (ACP):
a) The PI must be under an ACP or contributing to the growth and development of research in/under an ACP through active collaboration. Justifications must be given to support these research contributions and activities. Applicants will need to complete a self-declaration on the ACP to which their research has contributed and obtain acknowledgement from the respective ACP Vice Chair (Research)*.
*Refer to ‘ACP Academic Vice Chair, Research & Administrators Contact list’.
b) If the applicant is unable to fulfil the above condition (i), the applicant should have his/her proposal signed-off by the relevant ACP Vice Chair (Research) and have it endorsed by the ACP’s Academic Chair while keeping the respective ACP Administrators informed. The signing-off in support and as endorsement of the proposal signifies that the applicant is associated to the ACP.
The proposed research project must be conducted within the SingHealth Duke-NUS academic health system and the PI must have an official employment (permanent/contract) in a SingHealth institution throughout the effective grant period.
For proposals involving patients, the PI or Co-I should be Singapore Medical Council (SMC) or Singapore Dental Council (SDC) registered, as appropriate; or be able to demonstrate ability to access patients through SMC or SDC registered collaborators.
Under the Clinical Trial & Clinical Research categories, PI must be at least an SMC registered Associate Consultant or SDC registered (as appropriate; in compliance to HSA standard).
The project’s aims and objectives, and/or the same protocol have not been funded by other funding agencies.
No outstanding reports from previous SHF-Foundation/AM grants.
Applications that do not fulfil the eligibility criteria will be automatically disqualified from the SingHealth Duke-NUS AM Grant Research Committee (AGRC)’s or the respective platform-specific panels’ review.
To apply for the Special Category Grants, please ensure that you meet the relevant guidelines listed under the specific category prior to the application (refer to “SingHealth Duke-NUS AM Research Grant 2.0 FY2025 - Application Guidelines”).
Submission
Each eligible applicant can only submit one application per SingHealth Duke-NUS AM Research Grant Call as the PI (i.e. a PI can only apply for either ‘SingHealth Duke-NUS AM Research Grant 2.0 FY2025’ or ‘SingHealth Duke-NUS AM & NHIC Joint MedTech Grant Call FY2025’).
Within any single grant category or sub-category, project submissions from the same PI must be substantially and scientifically different (e.g. a PI may be awarded a Start-Up grant in 2014 and a second Start-Up grant in 2016 only if the research ideas of the two grants differ). Final arbitration will be made by the review committee.
Application must be endorsed by the applicant's Head of Department (HOD) and Residency Programme Director (if applicable) (*new*) prior to the submission to SingHealth Office of Research (OoR) through the Research Office of the Principal Investigator (PI)'s Host Institution. Only applications with following submissions received will be accepted:
(1 in word format without signatures and 1 in PDF format with signatures). Electronic signatures are allowed.
Important Notes:
Contact Person
SingHealth Office of Research (OoR)
Ms Tan Yi Mei; Email: tan.yi.mei@singhealth.com.sg
Ms Ang Shu Wei; Email: ang.shu.wei@singhealth.com.sg
Dr See Jie Yang: Email: see.jie.yang@singhealth.com.sg
Additional Information
Annex 1 - SingHealth Duke-NUS AM Research Grant Funding Guidelines.pdf
SingHealth Duke-NUS AM Research Grant 2.0 FY2025 - HSR-HEARTS Application Form.docx
SingHealth Duke-NUS AM Research Grant 2.0 FY2025 - Guidelines.pdf
SingHealth Institutional Research Admin Contact List (Aug 2024).pdf
ACP Academic Vice Chair, Research and Administrators Contact list (Aug 2024).pdf
© 2025 SingHealth Group. All Rights Reserved.